General information about AATD, novelties and innovation
There are still many people who wonder how the inhaler is used correctly. FEANER, the Spanish Federation of Associations of Allergic and Respiratory Diseases Patients, has organized a webinar, in which nurse Isabel Portela, explains how to properly use inhalation devices, for patients with asthma and COPD treatments. Isabel Portela, who is also a researcher […]
How to use the inhaler? Read More »
Grifols launches AlphaID ™, its free oral test that allows the diagnosis of most of the genetic variants that cause alpha-1 antitrypsin deficiency (AATD). AlphaID ™ makes it easy for clinicians to diagnose AATD, the leading known genetic risk factor for chronic obstructive pulmonary disease (COPD). Read more
Grifols Launches AlphaID ™ Read More »
The San Cecilio University Hospital has hosted the workshop “Learning to live with the AATD”, developed by Doctor Francisco Casas Maldonado, also coordinator of the Aldaluz Alfa-1 Center. Professionals from the Pulmonology Service of this hospital, located in the Health Technology Park, have participated, together with professionals from psychology and physiotherapy, in this workshop, which
Francisco Casas (Coordinator of the Andalusian Alpha-1 Center in Granada) and José Antonio Quintano (Spanish Society of Primary Care Physicians (SEMERGEN) have developed the Workshop for the diagnosis of alpha-1 antitrypsin deficiency (AATD), which has taken place during the IX SEMERGEN Respiratory Conference held in León on May 24 and 25, 2019. The workshop has
SEMERGEN-Respiratory alpha-1 antitrypsin deficiency diagnostic workshop Read More »
ALFACARE is a health activation and emotional support program aimed at patients with COPD due to alpha-1 antitrypsin deficiency (AATD) undergoing treatment with intravenous alpha-1 antitrypsin (AATD). Alfacare Program 2019 It is a pioneering program in activating the patient from home It has been designed to complement usual clinical care and treatment. The objectives of
Alfacare Program 2019 Read More »
An editorial has recently been published in the Archives of Bronchopneumology that analyzes the differences between the approved treatments for the treatment of pulmonary emphysema due to Alpha-1 deficiency. Esquinas C, Miravitlles M. Arch Bronconeumol. 2018;54:451-452. This publication reflects the differences between the approved treatments for pulmonary emphysema due to Alpha-1 atitrypsin deficiency in Spain,
